Preliminary programme items:
The Lewis Sheiner Student Session
- The annual Lewis Sheiner Student Session was inaugurated both to honour the memory of Lewis Sheiner, and to highlight his lifetime passion for student education. This year both the 2020 and 2021 Lewis Sheiner Student Sessions will be hosted and presented. Students who wish to be considered for the 2021 session should submit an extended abstract no later than 15 May 2021. Please note the following:
- The abstract must be structured with the following subheadings: Objectives / Methods / Results / Conclusion / References.
- There must be at least 6,000 but not more than 7,000 characters (including spaces) in the abstract text (excluding Title, Authors, Affiliation and References).
- The submitted work must have been performed either as part of an MSc or PhD programme and/or will ultimately form part of a PhD thesis.
- Each year a rotating committee of three members, representative of the PAGE community, will judge who should receive the honour of presenting in the Lewis Sheiner Student Session.
- Selected students will automatically receive a 300€ travel grant, to be carried over to the next occasion in which PAGE is hosted in-person. A permanent list of Lewis Sheiner presenters will be maintained on the website, along with links to their presentations.
- The Stuart Beal Methodology Session
As a tribute to the memory of Stuart Beal, PAGE hosts the Stuart Beal Methodology Session. The organising committee will choose presenters from the submitted abstracts.
- Special session on the role of pharmacometrics in vaccine and drug development for COVID-19
This session will be devoted to advances in COVID-19 treatment and the impact of pharmacometrics on these. Keynote speaker Professor Thorsten Lehr (of the Department of Pharmacy at Saarland University) will give a lecture with the title "Assessment of Immune Correlates of Protection in COVID-19 Vaccine Efficacy Trials", and Professor France Mentré and Dr Jérémie Guedj (of INSERM) will give a lecture on the role of pharmacometrics in the use of repurposed drugs in the treatment of COVID-19. Further presenters will be selected by the organising committee from the submitted abstracts - please submit abstracts under the special COVID-19 abstract categories.
- Keynote lecture on "Adaptive trial designs: opportunities and challenges" which will be given by Dr Vladimir Dragalin (of Janssen).
- Tutorial on competing risks in survival analysis
This presentation will provide a perspective on various aspects around time-to-event modelling with different types of events, including the presence of competing risks. Design of trials and clinical trial simulations in this context will also be discussed. The tutorial will be given by Professor Andrew Hooker (of Uppsala University) and Dr Joachim Grevel (of BAST). - This year's Oncology Session will be dedicated to the late Dr Laurent Claret and will be chaired by Dr René Bruno (of Genentech). The organising committee will choose presenters from the submitted abstracts.
- This year's Infectious Diseases Session will be dedicated to the late Professor Hartmut Derendorf and will be chaired by Dr Stephan Schmidt (of the University of Florida). The organising committee will choose presenters from the submitted abstracts.
Satellite meetings:
From PBPK To PBFTPK (Physiologically Based Finite Time Pharmacokinetic) Models
Wednesday, 1st September 2021, 15:00 (CET)
Athena Research Center has organized a half-day webinar focusing on physiologically based pharmacokinetic (PBPK) modeling and the recently developed physiologically based finite time pharmacokinetic (PBFTPK) models. There is a great deal of interest on this topic across academia, industry and regulators, as reflected by a new draft guidance by FDA.
The program of the webinar and the registration details can be found here. To register, please click here.